Last updated: May 19, 2022
Sponsor: University Hospital, Strasbourg, France
Overall Status: Active - Recruiting
Phase
N/A
Condition
Vascular Diseases
Circulation Disorders
Lupus
Treatment
N/AClinical Study ID
NCT05383573
8217
Ages 1-17 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria:
- Minor subject (<18 years old)
- Diagnosis of ANCA vasculitis according to the international criteria for defining thepathology, GPA or MPA form between 2011 and 2020.
- Subject (and/or his parental authority) who has not expressed, after being informed,his opposition to the reuse of his data for the purposes of this research.
Exclusion
Exclusion criteria:
- Subject (or his parents) having expressed his (their) opposition to participating inthe study
- Patients with vasculitis has ANCA in the form of EGPA
- Associated pathologies that cannot be related to the diagnosis of ANCA vasculitis andwhose prognosis can lead to biases in the efficacy and/or complications related totreatments.
Study Design
Total Participants: 500
Study Start date:
January 01, 2022
Estimated Completion Date:
December 31, 2022
Connect with a study center
Service de Pédiatrie 1 - CHU de Strasbourg - France
Strasbourg, 67091
FranceActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.